Tags

Type your tag names separated by a space and hit enter

Inclusion of pregnant women in COVID-19 vaccine development.
Lancet Infect Dis. 2020 09; 20(9):1007-1008.LI

Authors+Show Affiliations

Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London SW17 0RE, UK. Electronic address: pheath@sgul.ac.uk.Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London SW17 0RE, UK; Medical Research Council/Uganda Virus Research Institute at London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London SW17 0RE, UK; Fetal Medicine Unit, St George's Hospital, London, UK.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32795409

Citation

Heath, Paul T., et al. "Inclusion of Pregnant Women in COVID-19 Vaccine Development." The Lancet. Infectious Diseases, vol. 20, no. 9, 2020, pp. 1007-1008.
Heath PT, Le Doare K, Khalil A. Inclusion of pregnant women in COVID-19 vaccine development. Lancet Infect Dis. 2020;20(9):1007-1008.
Heath, P. T., Le Doare, K., & Khalil, A. (2020). Inclusion of pregnant women in COVID-19 vaccine development. The Lancet. Infectious Diseases, 20(9), 1007-1008. https://doi.org/10.1016/S1473-3099(20)30638-1
Heath PT, Le Doare K, Khalil A. Inclusion of Pregnant Women in COVID-19 Vaccine Development. Lancet Infect Dis. 2020;20(9):1007-1008. PubMed PMID: 32795409.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Inclusion of pregnant women in COVID-19 vaccine development. AU - Heath,Paul T, AU - Le Doare,Kirsty, AU - Khalil,Asma, Y1 - 2020/08/11/ PY - 2020/06/16/received PY - 2020/07/24/accepted PY - 2020/8/17/pubmed PY - 2020/9/8/medline PY - 2020/8/16/entrez SP - 1007 EP - 1008 JF - The Lancet. Infectious diseases JO - Lancet Infect Dis VL - 20 IS - 9 SN - 1474-4457 UR - https://www.unboundmedicine.com/medline/citation/32795409/Inclusion_of_pregnant_women_in_COVID_19_vaccine_development_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(20)30638-1 DB - PRIME DP - Unbound Medicine ER -